Intelligence Feed event · Macro · 2026-08-07

    Global Influenza Vaccine Market Projected to Reach $13.3B by 2030

    Question

    Global Influenza Vaccine Market Projected to Reach $13.3B by 2030

    Direct answer

    The influenza vaccine market is entering a period of steady growth, supported by increased public health awareness and the expansion of immunization programs in emerging markets. Major players like GSK and Sanofi are well-positioned to capture this growth through their established distribution networks.

    Original publisher
    Market Ontology
    Evidence through
    2026-08-07
    Published
    2026-10-20
    Revision
    1 · 2026-10-20

    Cite as: Market Ontology, “Global Influenza Vaccine Market Projected to Reach $13.3B by 2030”, revision 1, evidence through 2026-08-07. https://marketontology.com/market-events/2026-08-07/global-influenza-vaccine-market-projected-to-reach-13-3b-by-2030-d99f7d

    MACRO
    Global Influenza Vaccine Market Projected to Reach $13.3B by 2030
    The influenza vaccine market is entering a period of steady growth, supported by increased public health awareness and the expansion of immunization programs in emerging markets. Major players like GSK and Sanofi are well-positioned to capture this growth through their established distribution networks.
    GSKSNY
    Impact
    52
    AUG 7
    SIG
    80%
    GSKSNY
    Global Influenza Vaccine Market Projected to Reach $13.3B by 2030
    The influenza vaccine market is entering a period of steady growth, supported by increased public health awareness and the expansion of immunization programs in emerging markets. Major players like GSK and Sanofi are well-positioned to capture this growth through their established distribution networks.
    → Long-term revenue growth for major pharmaceutical players in the vaccine space.
    Impact
    The influenza vaccine market is entering a period of steady growth, supported by increased public health awareness and the expansion of immunization programs in emerging markets. Major players like GSK and Sanofi are well-positioned to capture this growth through their established distribution networks.
    Affected
    GSKSNY
    Transmission
    Long-term revenue growth for major pharmaceutical players in the vaccine space.

    Does this development affect your holdings?

    Enter your holdings to check them against this and other recent developments, review the decision that matters most, then set a monitor.

    Check this development against my holdings

    Review your initial audit before choosing ongoing portfolio scanning at $79/month.

    What happened next

    Price follow-up pending — no stored daily closes for these assets yet.

    Closing prices from stored daily bars; returns measured from the last close on or before the event date. Not a recommendation.

    No verifiable public source recorded for this card.

    Related

    Check this development against my holdings

    See today's live cards

    Public pages are published 24 hours after the product shows them. Desk shows every catalyst, event and causal reading as it happens, mapped to your holdings.

    Open Desk — $399/month